We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCJ icon
726
Cameco
CCJ
$38.3B
$132K ﹤0.01%
+14,272
New +$134K
SWN
727
DELISTED
Southwestern Energy Company
SWN
$75K ﹤0.01%
13,462
– –
EXK
728
Endeavour Silver
EXK
$2.32B
$57K ﹤0.01%
+24,000
New +$54.2K
GORO icon
729
Goldgroup Mining Inc.
GORO
$151M
$44K ﹤0.01%
10,000
– –
MUX icon
730
McEwen Inc
MUX
$1.03B
$32K ﹤0.01%
+1,400
New +$28.3K
SDRL
731
DELISTED
Seadrill Limited Common Stock
SDRL
$3K ﹤0.01%
49
– –
AMBA icon
732
Ambarella
AMBA
$2.99B
– –
-81,725
Closed -$4M
AOS icon
733
A.O. Smith
AOS
$8.38B
– –
-6,658
Closed -$396K
ASH icon
734
Ashland
ASH
$3.04B
– –
-7,000
Closed -$458K
ATR icon
735
AptarGroup
ATR
$8.45B
– –
-5,000
Closed -$432K
BC icon
736
Brunswick
BC
$5.19B
– –
-59,355
Closed -$3.32M
CPRT icon
737
Copart
CPRT
$25.9B
– –
-907,772
Closed -$7.8M
CPRX
738
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-560,000
Closed -$1.41M
DVA icon
739
DaVita
DVA
$15.1B
– –
-28,000
Closed -$1.66M
HIW icon
740
Highwoods Properties
HIW
$3.71B
– –
-9,000
Closed -$469K
HP icon
741
Helmerich & Payne
HP
$3.53B
– –
-9,357
Closed -$488K
HUBB icon
742
Hubbell
HUBB
$25.7B
– –
-95,424
Closed -$11.1M
INO icon
743
Inovio Pharmaceuticals
INO
$79.8M
– –
-5,000
Closed -$380K
JBGS
744
JBG SMITH
JBGS
$846M
– –
-60,743
Closed -$2.08M
JWN
745
DELISTED
Nordstrom
JWN
– –
-87,796
Closed -$4.14M
LAMR icon
746
Lamar Advertising Co
LAMR
$16.2B
– –
-7,000
Closed -$480K
LII icon
747
Lennox International
LII
$18.8B
– –
-1,755
Closed -$314K
LRMR icon
748
Larimar Therapeutics
LRMR
$416M
– –
-10,833
Closed -$458K
MKL icon
749
Markel Group
MKL
$25B
– –
-1,136
Closed -$1.21M
NI icon
750
NiSource
NI
$22.4B
– –
-8,876
Closed -$227K
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.